CS
AGN

Credit Suisse’s Allergan plc AGN Stock Holding History

Credit Suisse’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-22,300
Closed -$4.26M – 4361
2019
Q4 		$4.26M Hold
22,300
– – ﹤0.01% 1998
2019
Q3 		$3.75M Hold
22,300
– – ﹤0.01% 1985
2019
Q2 		$3.73M Buy
+22,300
New +$3.09M ﹤0.01% 1980
2019
Q1 		– Sell
-50,000
Closed -$6.68M – 4216
2018
Q4 		$6.68M Buy
50,000
+30,000
+150% +$4.92M 0.01% 1398
2018
Q3 		$3.81M Buy
+20,000
New +$3.67M ﹤0.01% 1880
2018
Q1 		– Sell
-35,000
Closed -$5.72M – 4211
2017
Q4 		$5.72M Sell
35,000
-50,000
-59% -$8.97M 0.01% 1686
2017
Q3 		$17.4M Sell
85,000
-55,000
-39% -$12.8M 0.02% 922
2017
Q2 		$34M Buy
140,000
+43,000
+44% +$10.1M 0.03% 545
2017
Q1 		$23.2M Buy
97,000
+80,000
+471% +$18.6M 0.02% 754
2016
Q4 		$3.57M Buy
+17,000
New +$3.52M ﹤0.01% 1925

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Credit Suisse's AGN Position: Q2 2020 in Review

Credit Suisse sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,733,794 shares — an estimated $1.9B sold.

Credit Suisse first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $1.9B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Credit Suisse reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Credit Suisse sold 10,733,794 Allergan plc shares in Q2 2020, an estimated $1.9B.
  • Credit Suisse first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Credit Suisse's Allergan plc position peaked at $1.9B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.